Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene therapy for hemophilia: an imperative to succeed.

Literature DB >> 15946210

Gene therapy for hemophilia: an imperative to succeed.

C Hough¹, D Lillicrap.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 15946210 DOI： 10.1111/j.1538-7836.2005.01401.x

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.

Authors: Joshua I Siner; Benjamin J Samelson-Jones; Julie M Crudele; Robert A French; Benjamin J Lee; Shanzhen Zhou; Elizabeth Merricks; Robin Raymer; Timothy C Nichols; Rodney M Camire; Valder R Arruda
Journal: JCI Insight Date: 2016-10-06

Review 2. Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.

Authors: David W Scott; Jay N Lozier
Journal: Br J Haematol Date: 2011-11-07 Impact factor: 6.998

Review 3. Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.

Authors: Christopher B Doering; David Archer; H Trent Spencer
Journal: Adv Drug Deliv Rev Date: 2010-09-30 Impact factor: 15.470

4. Gene Therapy for Inherited Bleeding Disorders.

Authors: Valder R Arruda; Jesse Weber; Benjamin J Samelson-Jones
Journal: Semin Thromb Hemost Date: 2021-02-26 Impact factor: 4.180

5. Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.

Authors: Marta Kucharska; Malgorzata Inglot; Aleksandra Szymczak; Weronika Rymer; Malgorzata Zalewska; Krzysztof Malyszczak; Urszula Zaleska-Dorobisz; Malgorzata Kuliszkiewicz-Janus
Journal: Hepat Mon Date: 2016-07-23 Impact factor: 0.660

6. Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo.

Authors: Wei Zhang; Jianhua Mao; Yan Shen; Guowei Zhang; Yanyan Shao; Zheng Ruan; Yun Wang; Wenman Wu; Xuefeng Wang; Jiang Zhu; Saijuan Chen; Weidong Xiao; Xiaodong Xi
Journal: Blood Cells Mol Dis Date: 2018-09-20 Impact factor: 3.039

Gene therapy for hemophilia: an imperative to succeed.

1. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.

Review 2. Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.

Review 3. Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.

4. Gene Therapy for Inherited Bleeding Disorders.

5. Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.

6. Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo.

7. Obstacles and future of gene therapy for hemophilia.

8. Seroprevalence of hepatitis C, hepatitis B and HIV viruses in hemophiliacs born 1985-2010 in west Azarbaijan of Iran.

Review 9. Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.

Review 10. Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century.